Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential

Page 9 of 9

1. Roivant Sciences Ltd. (NASDAQ:ROIV)

Upside Potential as of April 28: 301.91%

Viking Global’s Stake Value: $565,591,827

Number of Hedge Fund Holders: 44

Roivant Sciences Ltd. (NASDAQ:ROIV) is a biopharmaceutical company that develops and commercializes medicines and healthcare technologies. The company operates through its Vant subsidiaries, including Immunovant, Priovant, and others. It serves pharmaceutical markets globally.

Roivant Sciences Ltd.’s (NASDAQ:ROIV) third quarter ended December 31, 2024, financial report indicates a healthy company. By the end of 2024, the firm had approximately $5.2 billion of consolidated cash, cash equivalents, restricted cash, and marketable securities. This excludes the $75 million milestone from VTAMA’s approval in January 2025 and $113 million raised in Immunovant’s private placement, which raised Roivant’s ownership in Immunovant to 57%.

The company’s pipeline is growing, with Priovant starting a Phase 2 study of brepocitinib in cutaneous sarcoidosis and Immunovant launching trials of IMVT-1402 for Graves’ disease and rheumatoid arthritis; key data, including results from batoclimab’s myasthenia gravis trial, is expected in 2025. On April 22, 2025, H.C. Wainwright reiterated its Buy rating on Roivant Sciences Ltd. (NASDAQ:ROIV) with an $18.00 price target. The research firm maintained a positive outlook despite recent management changes.

While we acknowledge the potential of Roivant Sciences Ltd. (NASDAQ:ROIV) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ROIV but that trades at less than 5 times its earnings check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9